The EMJ Podcast | Bonus Episode
This podcast explores hematopoietic stem cell transplant in diffuse cutaneous systemic sclerosis (dcSSc) and the potential role of FCR001, an investigational allogeneic cell therapy. We are pleased to be joined by leading scleroderma expert Dinesh Khanna MD, MSc. Dr. Khanna is the Scleroderma Program Director at University of Michigan, USA, Dr. Khanna discusses the symptoms, severity, and progressiveness of scleroderma, focusing on dcSSc.
Spotify | Apple | Amazon Music | Download MP3 (mp3, 36:39 mins)
This podcast is funded and developed by Talaris Therapeutics, Inc. Talaris Therapeutics is a late-clinical stage cell therapy company that is developing an investigational allogeneic stem cell therapy.
